Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 49

  1. Cat.No. Product Name Information/Activity
  2. BCC7829 AA 29504 Positive allosteric modulator of GABA<sub>A</sub> receptors AA 29504 chemical structure
  3. BCC7737 Allopregnanolone GABA<sub>A</sub> receptor positive allosteric modulator Allopregnanolone chemical structure
  4. BCC7545 Alphaxalone 23930-19-0 Alphaxalone chemical structure
  5. BCC6830 Chlormethiazole hydrochloride 6001-74-7 Chlormethiazole hydrochloride chemical structure
  6. BCC7748 DS2 374084-31-8 DS2 chemical structure
  7. BCC1150 Etomidate Etomidate(R-16659) is a GABAA receptors agonist, which is a short acting intravenous anaesthetic agent used for the induction of general anaesthesia. Etomidate chemical structure
  8. BCC4456 Flupirtine maleate Flupirtine Maleate(D 9998) is a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties. Flupirtine maleate chemical structure
  9. BCC7397 Ganaxolone 38398-32-2 Ganaxolone chemical structure
  10. BCC7720 Indiplon 325715-02-4 Indiplon chemical structure
  11. BCC7009 Loreclezole hydrochloride Loreclezole, an antiepileptic compound, is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit containing receptors. Loreclezole hydrochloride chemical structure

Items 481 to 490 of 752 total